× Medicines Discovery Catapult

Royal Lancaster

Date(s) 11th - 12th November 2019     Time All Day


Pricing pressures in the US and a growing number of markets globally has already set in motion a search for new and innovative payment models, while the rise of ultra-expensive, potentially curative gene and cell therapies has brought to the fore a heated discussion about the sustainability of industry’s underlying economic and funding model.

With a host of ‘new entrants’ in the shape of big tech and nimble, consumer-centric start-ups nibbling at pharma’s heals in the emerging prevention and wellness space, meanwhile, pharma faces competition on an increasing number of fronts. Success in the new data and patient-centric world which is emerging will increasingly depend on the forging relationships with patients sustained on trust, and building new business models for the future.

Mark Samuels, our Chief Business & Strategy Officer, is on the Advisory Board for the event.

Register now

Loading Map....
Share
FT Global Pharmaceutical and Biotechnology Conference